
Randomized Double-blind, Active-controlled Phase 3 Study to Assess 12-Month Safety and Efficacy of Mirabegron, a β3-Adrenoceptor Agonist, in Overactive Bladder
Christopher R. Chapple, Steven A. Kaplan, David Mitcheson, Jiri Klecka, Jana Cummings, Ted Drogendijk, Caroline Dorrepaal, Nancy MartinVolume:
63
Année:
2013
Langue:
english
DOI:
10.1016/j.eururo.2012.10.048
Fichier:
PDF, 508 KB
english, 2013